Literature DB >> 20487031

Differential regulation of CaMKII inhibitor beta protein expression after exposure to a novel context and during contextual fear memory formation.

K Radwańska1, A A Tudor-Jones, K Mizuno, G S Pereira, W Lucchesi, I Alfano, A Łach, L Kaczmarek, S Knapp, K Peter Giese.   

Abstract

Understanding of the molecular basis of long-term fear memory (fear LTM) formation provides targets in the treatment of emotional disorders. Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is one of the key synaptic molecules involved in fear LTM formation. There are two endogenous inhibitor proteins of CaMKII, CaMKII N alpha and N beta, which can regulate CaMKII activity in vitro. However, the physiological role of these endogenous inhibitors is not known. Here, we have investigated whether CaMKII N beta protein expression is regulated after contextual fear conditioning or exposure to a novel context. Using a novel CaMKII N beta-specific antibody, CaMKII N beta expression was analysed in the naïve mouse brain as well as in the amygdala and hippocampus after conditioning and context exposure. We show that in naïve mouse forebrain CaMKII N beta protein is expressed at its highest levels in olfactory bulb, prefrontal and piriform cortices, amygdala and thalamus. The protein is expressed both in dendrites and cell bodies. CaMKII N beta expression is rapidly and transiently up-regulated in the hippocampus after context exposure. In the amygdala, its expression is regulated only by contextual fear conditioning and not by exposure to a novel context. In conclusion, we show that CaMKII N beta expression is differentially regulated by novelty and contextual fear conditioning, providing further insight into molecular basis of fear LTM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20487031     DOI: 10.1111/j.1601-183X.2010.00595.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  8 in total

1.  CaMKII inhibitor 1 (CaMK2N1) mRNA is upregulated following LTP induction in hippocampal slices.

Authors:  Daniela Astudillo; Daniel Karmelic; Barbara S Casas; Nikolai Otmakhov; Veronica Palma; Magdalena Sanhueza
Journal:  Synapse       Date:  2020-05-31       Impact factor: 2.562

Review 2.  CaMKII regulation in information processing and storage.

Authors:  Steven J Coultrap; K Ulrich Bayer
Journal:  Trends Neurosci       Date:  2012-06-19       Impact factor: 13.837

3.  Genomewide linkage analysis in Costa Rican families implicates chromosome 15q14 as a candidate region for OCD.

Authors:  Jessica Ross; Judith Badner; Helena Garrido; Brooke Sheppard; Denise A Chavira; Marco Grados; Jonathan M Woo; Pamela Doo; Paula Umaña; Eduardo Fournier; Sarah Shaw Murray; Carol A Mathews
Journal:  Hum Genet       Date:  2011-06-21       Impact factor: 4.132

4.  Effects of CaMKII inhibitor tatCN21 on activity-dependent redistribution of CaMKII in hippocampal neurons.

Authors:  J-H Tao-Cheng; Y Yang; K U Bayer; T S Reese; A Dosemeci
Journal:  Neuroscience       Date:  2013-04-11       Impact factor: 3.590

5.  On the mechanism of synaptic depression induced by CaMKIIN, an endogenous inhibitor of CaMKII.

Authors:  Camilo Gouet; Belen Aburto; Cecilia Vergara; Magdalena Sanhueza
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

6.  Improving a natural CaMKII inhibitor by random and rational design.

Authors:  Steven J Coultrap; K Ulrich Bayer
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

7.  Prevention of long-term memory loss after retrieval by an endogenous CaMKII inhibitor.

Authors:  Fabio Antonio Vigil; Keiko Mizuno; Walter Lucchesi; Victoria Valls-Comamala; Karl Peter Giese
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

8.  Protection of α-CaMKII from Dephosphorylation by GluN2B Subunit of NMDA Receptor Is Abolished by Mutation of Glu96 or His282 of α-CaMKII.

Authors:  Madhavan Mayadevi; Kesavan Lakshmi; Sudarsana Devi Suma Priya; Sebastian John; Ramakrishnapillai V Omkumar
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.